Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tachycardia induced myocardial dysfunction. A reversible phenomenon?

C J McLaran, B J Gersh, D D Sugrue

    British Heart Journal
    |March 1, 1985
    PubMed
    Summary

    Tachycardia-induced myocardial dysfunction can be reversible in some patients after controlling supraventricular tachycardia. Early intervention is crucial to prevent long-term heart muscle damage and improve cardiac function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Factors affecting radiation exposure in patients undergoing endoscopic treatment for urolithiasis.

    Urolithiasis·2024
    Same author

    Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 116: 2687-2693, 2007.

    Clinical journal of the American Society of Nephrology : CJASN·2023
    Same author

    Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial.

    Journal of internal medicine·2020
    Same author

    Effect of Low-Dose Rapamycin on Senescence Markers and Physical Functioning in Older Adults with Coronary Artery Disease: Results of a Pilot Study.

    The Journal of frailty & aging·2016
    Same author

    D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.

    Journal of thrombosis and haemostasis : JTH·2014
    Same author

    Diabetes, incretin hormones and cardioprotection.

    Heart (British Cardiac Society)·2014

    Area of Science:

    • Cardiology
    • Electrophysiology
    • Cardiac Imaging

    Background:

    • Tachycardia-induced cardiomyopathy is a recognized cause of heart muscle dysfunction.
    • Re-entrant supraventricular tachycardias (SVT) can precipitate myocardial impairment.
    • Understanding the reversibility of cardiac dysfunction is key for patient management.

    Observation:

    • Electrophysiological studies identified a re-entrant supraventricular tachycardia utilizing an accessory atrioventricular pathway in four patients.
    • Echocardiography demonstrated variable reversibility of left ventricular dysfunction after successful tachycardia control.
    • Endomyocardial biopsies revealed non-specific histological findings in affected individuals.

    Findings:

    • Supraventricular tachycardia associated with accessory atrioventricular connections can lead to reversible myocardial dysfunction.

    Related Experiment Videos

  • The degree of left ventricular function recovery varies among patients.
  • Histological changes in the myocardium are generally non-specific.

    • Implications:

    • Effective and timely control of prolonged tachycardia is essential to prevent irreversible myocardial damage.
    • This highlights the importance of early diagnosis and treatment of SVT to preserve cardiac function.
    • Further research into the mechanisms of tachycardia-induced cardiomyopathy is warranted.